By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Quanta BioSciences today announced a partnership with Integrated DNA Technologies for the manufacture of assays for quantifying microRNAs.

Under the terms of the deal, IDT will produce the assays and market them through an online catalog directly to customers of Quanta.

Financial and other terms of the deal were not disclosed.

Based in Gaithersburg, Md., Quanta develops reagents for PCR, qPCR, and cDNA applications.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.